Allorion Therapeutics is a series a startup. 1 investor tracked. Status: possibledead.
Based in the United States, Allorion Therapeutics is a startup. Its most recent tracked round is Series A. Brouky records 2 investors associated with the company.
Allorion Therapeutics is a biotechnology company.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.